In the BioHarmony Drug Report Database

"Preview" Icon

Methysergide

Sansert (methysergide) is a small molecule pharmaceutical. Methysergide was first approved as Sansert on 1982-01-01. It is used to treat vascular headaches in the USA. The pharmaceutical is active against 5-hydroxytryptamine receptor 2C and 5-hydroxytryptamine receptor 2B. In addition, it is known to target 5-hydroxytryptamine receptor 1E, 5-hydroxytryptamine receptor 1B, 5-hydroxytryptamine receptor 7, 5-hydroxytryptamine receptor 6, 5-hydroxytryptamine receptor 1F, 5-hydroxytryptamine receptor 1D, 5-hydroxytryptamine receptor 2A, and 5-hydroxytryptamine receptor 5A.

 

Trade Name

 

Sansert
 

Common Name

 

methysergide
 

ChEMBL ID

 

CHEMBL485253
 

Indication

 

vascular headaches
 

Drug Class

 

Ergot alkaloid derivatives

Image (chem structure or protein)

Methysergide structure rendering